Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease

Domenico Lio, Giorgio Annoni, Federico Licastro, Antonino Crivello, Giusi Irma Forte, Letizia Scola, Giuseppina Colonna-Romano, Giuseppina Candore, Beatrice Arosio, Lorenza Galimberti, Carlo Vergani, Calogero Caruso

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Pro-inflammatory cytokines and acute-phase proteins play an important role in Alzheimer's disease (AD) neurodegeneration, and common polymorphisms of genes controlling their production have been shown to be associated with AD. Tumor necrosis factor (TNF)-α is an inflammatory cytokine involved in the local immune response occurring in the central nervous system of AD patients. Genetic variation could contribute to the risk of developing AD or influence the age at the onset of the disease. We genotyped 222 patients (152 women, 70 men; age range 60-87) and 240 non-demented age-matched healthy controls for TNF-α -308 G/A single nucleotide polymorphism (SNP). No significant differences were observed in genotyped frequencies between patients and controls, whereas carriers of -308A showed a significantly lower mean age at onset than non-carriers of this allele. This difference was more evident taking into account ApolipoproteinE (ApoE) status since the lowest age at onset was observed in patients carrying the -308ATNF+/APOE4+ genotypes. In conclusion, our data support previous suggestions that, at least in Caucasians, the TNF gene is a disease modifier gene in patients in which AD is rising, bringing to light the importance of genetic variation at the pro-inflammatory components in the progression of AD.

Original languageEnglish
Pages (from-to)567-571
Number of pages5
JournalMechanisms of Ageing and Development
Volume127
Issue number6
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Polymorphism
Age of Onset
Alzheimer Disease
Tumor Necrosis Factor-alpha
Modifier Genes
Cytokines
Acute-Phase Proteins
Genes
Central Nervous System Diseases
Single Nucleotide Polymorphism
Neurology
Alleles
Genotype
Nucleotides

Keywords

  • Alzheimer's disease
  • Cytokine
  • Inflammation
  • SNP
  • TNF-α

ASJC Scopus subject areas

  • Ageing
  • Biochemistry
  • Developmental Biology
  • Developmental Neuroscience

Cite this

Lio, D., Annoni, G., Licastro, F., Crivello, A., Forte, G. I., Scola, L., ... Caruso, C. (2006). Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mechanisms of Ageing and Development, 127(6), 567-571. https://doi.org/10.1016/j.mad.2006.01.015

Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease. / Lio, Domenico; Annoni, Giorgio; Licastro, Federico; Crivello, Antonino; Forte, Giusi Irma; Scola, Letizia; Colonna-Romano, Giuseppina; Candore, Giuseppina; Arosio, Beatrice; Galimberti, Lorenza; Vergani, Carlo; Caruso, Calogero.

In: Mechanisms of Ageing and Development, Vol. 127, No. 6, 06.2006, p. 567-571.

Research output: Contribution to journalArticle

Lio, D, Annoni, G, Licastro, F, Crivello, A, Forte, GI, Scola, L, Colonna-Romano, G, Candore, G, Arosio, B, Galimberti, L, Vergani, C & Caruso, C 2006, 'Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease', Mechanisms of Ageing and Development, vol. 127, no. 6, pp. 567-571. https://doi.org/10.1016/j.mad.2006.01.015
Lio, Domenico ; Annoni, Giorgio ; Licastro, Federico ; Crivello, Antonino ; Forte, Giusi Irma ; Scola, Letizia ; Colonna-Romano, Giuseppina ; Candore, Giuseppina ; Arosio, Beatrice ; Galimberti, Lorenza ; Vergani, Carlo ; Caruso, Calogero. / Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease. In: Mechanisms of Ageing and Development. 2006 ; Vol. 127, No. 6. pp. 567-571.
@article{97a572dde8cd43f290a156be268280b4,
title = "Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease",
abstract = "Pro-inflammatory cytokines and acute-phase proteins play an important role in Alzheimer's disease (AD) neurodegeneration, and common polymorphisms of genes controlling their production have been shown to be associated with AD. Tumor necrosis factor (TNF)-α is an inflammatory cytokine involved in the local immune response occurring in the central nervous system of AD patients. Genetic variation could contribute to the risk of developing AD or influence the age at the onset of the disease. We genotyped 222 patients (152 women, 70 men; age range 60-87) and 240 non-demented age-matched healthy controls for TNF-α -308 G/A single nucleotide polymorphism (SNP). No significant differences were observed in genotyped frequencies between patients and controls, whereas carriers of -308A showed a significantly lower mean age at onset than non-carriers of this allele. This difference was more evident taking into account ApolipoproteinE (ApoE) status since the lowest age at onset was observed in patients carrying the -308ATNF+/APOE4+ genotypes. In conclusion, our data support previous suggestions that, at least in Caucasians, the TNF gene is a disease modifier gene in patients in which AD is rising, bringing to light the importance of genetic variation at the pro-inflammatory components in the progression of AD.",
keywords = "Alzheimer's disease, Cytokine, Inflammation, SNP, TNF-α",
author = "Domenico Lio and Giorgio Annoni and Federico Licastro and Antonino Crivello and Forte, {Giusi Irma} and Letizia Scola and Giuseppina Colonna-Romano and Giuseppina Candore and Beatrice Arosio and Lorenza Galimberti and Carlo Vergani and Calogero Caruso",
year = "2006",
month = "6",
doi = "10.1016/j.mad.2006.01.015",
language = "English",
volume = "127",
pages = "567--571",
journal = "Mechanisms of Ageing and Development",
issn = "0047-6374",
publisher = "Elsevier Ireland Ltd",
number = "6",

}

TY - JOUR

T1 - Tumor necrosis factor-α-308A/G polymorphism is associated with age at onset of Alzheimer's disease

AU - Lio, Domenico

AU - Annoni, Giorgio

AU - Licastro, Federico

AU - Crivello, Antonino

AU - Forte, Giusi Irma

AU - Scola, Letizia

AU - Colonna-Romano, Giuseppina

AU - Candore, Giuseppina

AU - Arosio, Beatrice

AU - Galimberti, Lorenza

AU - Vergani, Carlo

AU - Caruso, Calogero

PY - 2006/6

Y1 - 2006/6

N2 - Pro-inflammatory cytokines and acute-phase proteins play an important role in Alzheimer's disease (AD) neurodegeneration, and common polymorphisms of genes controlling their production have been shown to be associated with AD. Tumor necrosis factor (TNF)-α is an inflammatory cytokine involved in the local immune response occurring in the central nervous system of AD patients. Genetic variation could contribute to the risk of developing AD or influence the age at the onset of the disease. We genotyped 222 patients (152 women, 70 men; age range 60-87) and 240 non-demented age-matched healthy controls for TNF-α -308 G/A single nucleotide polymorphism (SNP). No significant differences were observed in genotyped frequencies between patients and controls, whereas carriers of -308A showed a significantly lower mean age at onset than non-carriers of this allele. This difference was more evident taking into account ApolipoproteinE (ApoE) status since the lowest age at onset was observed in patients carrying the -308ATNF+/APOE4+ genotypes. In conclusion, our data support previous suggestions that, at least in Caucasians, the TNF gene is a disease modifier gene in patients in which AD is rising, bringing to light the importance of genetic variation at the pro-inflammatory components in the progression of AD.

AB - Pro-inflammatory cytokines and acute-phase proteins play an important role in Alzheimer's disease (AD) neurodegeneration, and common polymorphisms of genes controlling their production have been shown to be associated with AD. Tumor necrosis factor (TNF)-α is an inflammatory cytokine involved in the local immune response occurring in the central nervous system of AD patients. Genetic variation could contribute to the risk of developing AD or influence the age at the onset of the disease. We genotyped 222 patients (152 women, 70 men; age range 60-87) and 240 non-demented age-matched healthy controls for TNF-α -308 G/A single nucleotide polymorphism (SNP). No significant differences were observed in genotyped frequencies between patients and controls, whereas carriers of -308A showed a significantly lower mean age at onset than non-carriers of this allele. This difference was more evident taking into account ApolipoproteinE (ApoE) status since the lowest age at onset was observed in patients carrying the -308ATNF+/APOE4+ genotypes. In conclusion, our data support previous suggestions that, at least in Caucasians, the TNF gene is a disease modifier gene in patients in which AD is rising, bringing to light the importance of genetic variation at the pro-inflammatory components in the progression of AD.

KW - Alzheimer's disease

KW - Cytokine

KW - Inflammation

KW - SNP

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=33646147149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646147149&partnerID=8YFLogxK

U2 - 10.1016/j.mad.2006.01.015

DO - 10.1016/j.mad.2006.01.015

M3 - Article

VL - 127

SP - 567

EP - 571

JO - Mechanisms of Ageing and Development

JF - Mechanisms of Ageing and Development

SN - 0047-6374

IS - 6

ER -